206 related articles for article (PubMed ID: 28315267)
1. Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain.
Merlos M; Burgueño J; Portillo-Salido E; Plata-Salamán CR; Vela JM
Adv Exp Med Biol; 2017; 964():85-107. PubMed ID: 28315267
[TBL] [Abstract][Full Text] [Related]
2. Sigma-1 Receptor and Pain.
Merlos M; Romero L; Zamanillo D; Plata-Salamán C; Vela JM
Handb Exp Pharmacol; 2017; 244():131-161. PubMed ID: 28275913
[TBL] [Abstract][Full Text] [Related]
3. Antinociception by Sigma-1 Receptor Antagonists: Central and Peripheral Effects.
Romero L; Merlos M; Vela JM
Adv Pharmacol; 2016; 75():179-215. PubMed ID: 26920013
[TBL] [Abstract][Full Text] [Related]
4. Sigma-1 Receptor Antagonists: A New Class of Neuromodulatory Analgesics.
Sánchez-Fernández C; Entrena JM; Baeyens JM; Cobos EJ
Adv Exp Med Biol; 2017; 964():109-132. PubMed ID: 28315268
[TBL] [Abstract][Full Text] [Related]
5. Investigational sigma-1 receptor antagonists for the treatment of pain.
Vela JM; Merlos M; Almansa C
Expert Opin Investig Drugs; 2015; 24(7):883-96. PubMed ID: 26037209
[TBL] [Abstract][Full Text] [Related]
6. Selective sigma-1 receptor antagonists for the treatment of pain.
Almansa C; Vela JM
Future Med Chem; 2014 Jun; 6(10):1179-99. PubMed ID: 25078137
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.
Romero L; Zamanillo D; Nadal X; Sánchez-Arroyos R; Rivera-Arconada I; Dordal A; Montero A; Muro A; Bura A; Segalés C; Laloya M; Hernández E; Portillo-Salido E; Escriche M; Codony X; Encina G; Burgueño J; Merlos M; Baeyens JM; Giraldo J; López-García JA; Maldonado R; Plata-Salamán CR; Vela JM
Br J Pharmacol; 2012 Aug; 166(8):2289-306. PubMed ID: 22404321
[TBL] [Abstract][Full Text] [Related]
8. Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice.
Castany S; Gris G; Vela JM; Verdú E; Boadas-Vaello P
Sci Rep; 2018 Mar; 8(1):3873. PubMed ID: 29497125
[TBL] [Abstract][Full Text] [Related]
9. Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.
Sahn JJ; Mejia GL; Ray PR; Martin SF; Price TJ
ACS Chem Neurosci; 2017 Aug; 8(8):1801-1811. PubMed ID: 28644012
[TBL] [Abstract][Full Text] [Related]
10. The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control.
Rodríguez-Muñoz M; Sánchez-Blázquez P; Herrero-Labrador R; Martínez-Murillo R; Merlos M; Vela JM; Garzón J
Antioxid Redox Signal; 2015 Apr; 22(10):799-818. PubMed ID: 25557043
[TBL] [Abstract][Full Text] [Related]
11. Sigma-1 receptors and animal studies centered on pain and analgesia.
Davis MP
Expert Opin Drug Discov; 2015; 10(8):885-900. PubMed ID: 26037105
[TBL] [Abstract][Full Text] [Related]
12. The selective sigma-1 receptor antagonist E-52862 attenuates neuropathic pain of different aetiology in rats.
Gris G; Portillo-Salido E; Aubel B; Darbaky Y; Deseure K; Vela JM; Merlos M; Zamanillo D
Sci Rep; 2016 Apr; 6():24591. PubMed ID: 27087602
[TBL] [Abstract][Full Text] [Related]
13. Bifunctional μ opioid and σ
Zhuang T; Xiong J; Hao S; Du W; Liu Z; Liu B; Zhang G; Chen Y
Eur J Med Chem; 2021 Nov; 223():113658. PubMed ID: 34175542
[TBL] [Abstract][Full Text] [Related]
14. The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception.
Sánchez-Blázquez P; Cortés-Montero E; Rodríguez-Muñoz M; Merlos M; Garzón-Niño J
Mol Brain; 2020 Nov; 13(1):150. PubMed ID: 33176836
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effect of LMH-2, a new sigma-1 receptor antagonist analog of haloperidol, on the neuropathic pain of diabetic mice.
Ventura-Martínez R; Ángeles-López GE; González-Ugalde D; Domínguez-Páez T; Navarrete-Vázquez G; Jaimez R; Déciga-Campos M
Biomed Pharmacother; 2024 May; 174():116524. PubMed ID: 38574622
[TBL] [Abstract][Full Text] [Related]
16. Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice.
Nieto FR; Cendán CM; Cañizares FJ; Cubero MA; Vela JM; Fernández-Segura E; Baeyens JM
Mol Pain; 2014 Feb; 10():11. PubMed ID: 24517272
[TBL] [Abstract][Full Text] [Related]
17. Sigma 1 receptor: a new therapeutic target for pain.
Zamanillo D; Romero L; Merlos M; Vela JM
Eur J Pharmacol; 2013 Sep; 716(1-3):78-93. PubMed ID: 23500210
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of N‑(benzylpiperidinyl)‑4‑fluorobenzamide: A haloperidol analog that reduces neuropathic nociception via σ
Déciga-Campos M; Melo-Hernández LA; Torres-Gómez H; Wünsch B; Schepmann D; González-Trujano ME; Espinosa-Juárez J; López-Muñoz FJ; Navarrete-Vázquez G
Life Sci; 2020 Mar; 245():117348. PubMed ID: 31981633
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effects of a new sigma-1 receptor antagonist (N-(2-morpholin-4-yl-ethyl)-2-(1-naphthyloxy)acetamide) in two types of nociception.
García-Martínez BA; Jaramillo-Morales OA; Espinosa-Juárez JV; Navarrete-Vázquez G; Melo-Hernández LA; Medina-López JR; Domínguez-Ramírez AM; Schepmann D; Wünsch B; López-Muñoz FJ
Eur J Pharmacol; 2016 Jan; 771():10-7. PubMed ID: 26683636
[TBL] [Abstract][Full Text] [Related]
20. Optimization of bifunctional piperidinamide derivatives as σ
Xiong J; Zhuang T; Ma Y; Xu J; Ye J; Ma R; Zhang S; Liu X; Liu BF; Hao C; Zhang G; Chen Y
Eur J Med Chem; 2021 Dec; 226():113879. PubMed ID: 34628236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
